Advertisement
Screener

EXOZYMES INC. (EXOZ) Total Assets

EXOZYMES INC. Total Assets

EXOZYMES INC. (EXOZ) had Total Assets of $7.98 million as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Balance Sheet › Assets

us-gaap:Assets · last filed 2026-08-13

  • 2026-06-30: Assets $7.98M.
  • 2026-03-31: Assets $4.02M.
  • 2025-12-31: Assets $5.97M.
  • 2025-09-30: Assets $7.72M.
Period endAssets
2026-06-30$7.98M
10-Q · filed 2026-08-13
2026-03-31$4.02M
10-Q · filed 2026-05-14
2025-12-31$5.97M
10-Q · filed 2026-08-13
2025-09-30$7.72M
10-Q · filed 2025-11-13
2025-06-30$9.68M
10-Q · filed 2025-08-12
2025-03-31$11.53M
10-Q · filed 2025-05-12
2024-12-31$13.03M
10-K · filed 2026-03-30
2024-09-30$3.56M
10-Q · filed 2024-11-12
2023-12-31$3.56M
10-K · filed 2025-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
BioStem Technologies, Inc. (BSEM)United States$0.069B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02